Family-owned Juvisé Pharmaceuticals, a France-based specialty pharma, has completed a €550m (US$655m) refinancing (including €400m of existing debt and a new €150m capital expenditure line fully dedicated to future M&A…
France: Juvisé Pharmaceuticals secures €550m refinancing from Hayfin Capital Management
…
…






